世界の自動体外式除細動器（AED）市場 - 成長、トレンド、および予測（2019年 - 2024年）

世界の自動体外式除細動器（AED）市場は、2019年から20204年の間に7.8％のCAGRで成長するすることが予測されます。主な市場成長要因には、心血管疾患の罹患率の上昇、除細動器の分野における技術の進歩、および政府や民間企業による投資の増加などが挙げられます。

当レポートでは世界の自動体外式除細動器（AED）市場について調査しており、市場概況や成長要因・阻害要因、競合情勢、分析タイプ・エンドユーザー・地域別の市場分析、主要企業のプロファイル等の情報をまとめています。

目次

第1章 イントロダクション

• 研究成果
• 調査の前提条件
• 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

• 市場概況
• 市場成長要因
  • 心血管疾患の罹患率の上昇
  • 除細動器の分野における技術の進歩
  • 投資の増加
• 市場阻害要因
  • 厳しい規制
  • 心臓突然死（SAC）に対する意識の欠如
• ポーターファイブフォース分析
  • 新規参入の脅威
  • バイヤー/消費者の交渉力
  • サプライヤーの交渉力
  • 代替製品の脅威
  • 業界内の競争

第5章 市場セグメント

• 分析タイプ別
  • 半自動体外式除細動器
  • 全自動体外式除細動器
• エンドユーザー別
  • 病院/診療所
  • ホームケア
  • 救急医療
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中東およびアフリカ
  • 南米

第6章 競合情勢

• 企業プロファイル
  • 旭化成株式会社
  • Cardiac Science
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • 日本光電工業株式会社
  • Schiller
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • Stryker Corporation

第7章 市場機会および今後の動向

Market Overview

Global Automated External Defibrillator market is expected to witness a CAGR of 7.8% during the forecast period. Certain factors that are driving the market growth include rising prevalence of cardiovascular diseases, technological advancements in the field of defibrillators, and increasing investments by government and private players.

The automated external defibrillator market saw growth due to the rise in the prevalence of cardiovascular diseases (CVDs). As per the recent report of the World Health Organization (WHO), more people die from CVDs than any other disease prevalence. In 2015, around 17.7 million people died due to CVDs. A two-thirds of CVDs death accounts from low and middle-income countries. The statistics show the need for early detection and proper management which ultimately helps the market to grow globally. The rise in the technological advancements in defibrillators and rise in the investments from private players also help in the growth of this market.

However, the devices face much stricter regulations compared to those of other categories, taking longer time and labor for the complete approval process, this is one of the biggest factors to hinder the growth of the automated external defibrillator market. For example, in 2015, the US FDA ordered PMA approval for new and existing automated external defibrillators, citing manufacturing issues and recalled more than 2 million devices since 2005 for stricter regulations, thus, hindering the growth of this market. Along with this, there is a lack of awareness among people towards taking corrective actions at the earliest in relation to sudden cardiac arrest, especially in the emerging markets, which also hampers the growth of this market.

Scope of the Report

An automated external defibrillator (AED) is a lightweight, portable device that delivers an electric shock through the chest to the heart. The shock can potentially stop an irregular heartbeat and allow a normal rhythm to resume, following a sudden cardiac arrest (SCA). The scope of the report includes several market factors into considerations and the revenue share is divided into the following segments.

Key Market Trends

Semi-Automated External Defibrillators is Expected to Hold Significant Market Share in Analysis Type

Semi-automated external defibrillator (SAED) is a portable device that checks the heart's rhythm and allows the user to send an electric shock to the heart, for restoring the heart's normal rhythm. It is used to treat sudden cardiac arrests in patients. The major difference between a SAED and a fully automated external defibrillator (FAED) is that the fully automated ones send a shock automatically to the heart, after verbally preparing the patient to receive the shock. The SAED allows the patient to take the decision of sending a shock, after verbally requesting them; the SAED contains a shock button. One of the factors that contribute to the increase in SAED demand and its usage growing demand over the high medical tourism dedicated countries globally, across a range of multi-specialty hospitals. In the case of FAEDs, it should be made sure that no one is touching the patient, or else there is a chance that the person next to the patient might get injured by the shock.

North America Dominates the Market and Expected to do Same in the Forecasted Period

North America is expected to dominate the market owing to the increased prevalence of cardiovascular diseases and advancement in medical technology. The high healthcare expenditure and supportive government policies help this region to dominate this market. It is estimated that Europe is to follow North America due to rising prevalence of coronary artery diseases and a high number of sudden cardiac arrest with rising investments by companies in this region.

Competitive Landscape

The global Automated External Defibrillator market is highly competitive and consists of a number of major players. Companies like Asahi Kasei Corporation, Cardiac Science, GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Schiller, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, and Stryker Corporation, among others, hold the substantial market share in the Automated External Defibrillator market.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• Report customization as per the client's requirements
• 3 months of analyst support

Table of Contents

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence of Cardiovascular Diseases
  • 4.2.2 Technological Advancements in the Field of Defibrillators
  • 4.2.3 Increasing Investments by Private Players
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulations
  • 4.3.2 Lack of Awareness and Early Corrective Measures about Sudden Cardiac Arrest (SAC)
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 Analysis Type
  • 5.1.1 Semi-Automated External Defibrillators
  • 5.1.2 Fully Automated External Defibrillators
• 5.2 End User
  • 5.2.1 Hospitals/Clinics
  • 5.2.2 Home Care
  • 5.2.3 Emergency Care
  • 5.2.4 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 US
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 UK
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Asahi Kasei Corporation
  • 6.1.2 Cardiac Science
  • 6.1.3 GE Healthcare
  • 6.1.4 Koninklijke Philips N.V.
  • 6.1.5 Medtronic PLC
  • 6.1.6 Nihon Kohden Corporation
  • 6.1.7 Schiller
  • 6.1.8 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
  • 6.1.9 Stryker Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS